dpp4 vs sglt2 vs glp-1 PDF] Effects Of Analogues, DPP-4 Inhibitors And Inhibitors On The Renal System Expert Opinion: Optimum Clinical Approach

All trials analyzed the composite of 3 major adverse cardiovascular events (MACE), which included cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke, except the lixisenatide study that considered 4-point MACE, which also included hospitalization for heart failure (Table 1).5764 Although all the studies with arGLP-1 have demonstrated cardiovascular safety (noninferiority vs

Animal studies suggest sublingual bioavailability may be significantly higher than oral tablet bioavailability

Neuropharmacology 123, 6779

There may be legitimate circumstances where compounding is discussed, but patients should understand sourcing, dosing, regulatory status, quality control, and safety risks before using any product advertised online

The decision was already made

Some case reports show that GLP-1RA treatment initiation in patients leads to worsened Pso lesions, possibly because the drug triggers immune dysregulation, which results in increased pro-inflammatory pathways [19,65]